Hannah Joseph Hospital Limited Reports Insider Share Acquisition of 26,000 Equity Shares by Senior Management Personnel
Hannah Joseph Hospital Limited disclosed that Dr. Natarajan Arunkumar, senior management personnel, acquired 26,000 equity shares worth Rs. 16,19,420 through three on-market transactions on BSE between February and March 2026. His shareholding increased from 60,060 shares (0.26%) to 86,060 shares (0.38%). The company reported this insider trading activity to BSE on April 06, 2026, in compliance with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Hannah Joseph Hospital Limited has announced that Dr. Natarajan Arunkumar, a designated person and senior management personnel of the company, has acquired 26,000 equity shares through multiple market transactions. The disclosure was made to BSE Limited on April 06, 2026, in compliance with SEBI insider trading regulations.
Share Acquisition Details
Dr. Natarajan Arunkumar completed the share acquisition through three separate transactions conducted over a two-month period. The purchases were executed on the BSE through on-market transactions with a combined value of Rs. 16,19,420.
| Transaction Details: | Information |
|---|---|
| Total Shares Acquired: | 26,000 |
| Transaction Value: | Rs. 16,19,420 |
| Acquisition Period: | February 05, 2026 to March 30, 2026 |
| Exchange: | BSE |
| Mode: | On Market |
Transaction Breakdown
The acquisition was structured across three separate purchase dates, demonstrating a systematic approach to building the equity position.
| Date: | Shares Acquired: |
|---|---|
| February 05, 2026: | 2,000 |
| March 13, 2026: | 14,000 |
| March 30, 2026: | 10,000 |
Shareholding Position
Following the completion of these transactions, Dr. Arunkumar's total shareholding in Hannah Joseph Hospital Limited has increased significantly. His updated position reflects a notable increase in both absolute share count and percentage ownership.
| Shareholding Metric: | Before Acquisition | After Acquisition |
|---|---|---|
| Number of Shares: | 60,060 | 86,060 |
| Percentage Holding: | 0.26% | 0.38% |
Regulatory Compliance
The company received the disclosure from Dr. Natarajan Arunkumar on April 01, 2026, pursuant to Regulation 7(2)(a) of the SEBI Insider Trading Regulations. Hannah Joseph Hospital Limited subsequently informed BSE Limited on April 06, 2026, fulfilling its obligations under Regulation 7(2)(b) of the same regulations. The disclosure was submitted in the prescribed Form C format, providing comprehensive details of the transactions including dates, quantities, and transaction values.
Company Information
Hannah Joseph Hospital Limited operates as a healthcare institution specializing in neurosciences, cardiac sciences, orthopaedics, and traumatology. The company is listed on BSE with scrip code 544687 and trades under the symbol HANNAH. The hospital maintains NABH accreditation and operates from its corporate office in Madurai, Tamil Nadu.
Historical Stock Returns for Hannah Joseph Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.32% | -10.00% | +20.70% | +5.49% | +5.49% | +5.49% |
What strategic initiatives or expansion plans might Hannah Joseph Hospital be pursuing that prompted this insider's increased investment confidence?
How will the hospital's specialized focus on neurosciences and cardiac sciences position it against competitors in the evolving Indian healthcare market?
Could this insider buying signal potential acquisition interest or partnership opportunities for Hannah Joseph Hospital in the near term?



























